{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:24:27Z","timestamp":1773833067306,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["1804123N"],"award-info":[{"award-number":["1804123N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0C8920 N"],"award-info":[{"award-number":["G0C8920 N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010648","name":"Universitaire Ziekenhuizen Leuven, KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002910","name":"F\u00e9d\u00e9ration Wallonie-Bruxelles","doi-asserted-by":"publisher","award":["40001075"],"award-info":[{"award-number":["40001075"]}],"id":[{"id":"10.13039\/501100002910","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1053\/j.akdh.2023.01.007","type":"journal-article","created":{"date-parts":[[2023,4,21]],"date-time":"2023-04-21T20:54:09Z","timestamp":1682110449000},"page":"236-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Autosomal Dominant Polycystic Kidney Disease in Children and Adolescents: Assessing and Managing Risk of Progression"],"prefix":"10.1053","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4895-3084","authenticated-orcid":false,"given":"Ang\u00e9lique","family":"Dachy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6712-2489","authenticated-orcid":false,"given":"Liselotte","family":"Van Loo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0954-6088","authenticated-orcid":false,"given":"Djalila","family":"Mekahli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib1","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1681\/ASN.2018050493","article-title":"Prevalence estimates of polycystic kidney and liver disease by population sequencing","volume":"29","author":"Lanktree","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.akdh.2023.01.007_bib2","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib3","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ki.2014.120","article-title":"Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease","volume":"86","author":"Spithoven","year":"2014","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5414\/CNP57208","article-title":"Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival","volume":"57","author":"Abbott","year":"2002","journal-title":"Clin Nephrol"},{"issue":"9569","key":"10.1053\/j.akdh.2023.01.007_bib5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib6","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1053\/j.ajkd.2008.05.015","article-title":"Presence of de novo mutations in autosomal dominant polycystic kidney disease patients without family history","volume":"52","author":"Reed","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1053\/j.ackd.2010.01.003","article-title":"Extrarenal manifestations of autosomal dominant polycystic kidney disease","volume":"17","author":"Pirson","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2023.01.007_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrneph.2009.13","article-title":"Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease","volume":"5","author":"Ecder","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2016.06.017","article-title":"Gastrointestinal manifestations of autosomal-dominant polycystic kidney disease","volume":"15","author":"Mikolajczyk","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"20","key":"10.1053\/j.akdh.2023.01.007_bib10","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib11","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","article-title":"The spectrum of autosomal dominant polycystic kidney disease in children","volume":"4","author":"Fick","year":"1994","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00467-006-0327-8","article-title":"Prognosis of autosomal dominant polycystic kidney disease diagnosed in utero or at birth","volume":"22","author":"Boyer","year":"2007","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib13","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1681\/ASN.2015010016","article-title":"The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease","volume":"27","author":"Le Gall","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.ajkd.2020.12.020","article-title":"Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special Considerations for disease-modifying therapy","volume":"78","author":"Chebib","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"25","key":"10.1053\/j.akdh.2023.01.007_bib16","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"Torres","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfab312","article-title":"An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA working group on inherited kidney disorders, the european rare kidney disease reference network and polycystic kidney disease Inte","volume":"37","author":"M\u00fcller","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib18","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0002-9440(10)64919-X","article-title":"Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development","volume":"160","author":"Chauvet","year":"2002","journal-title":"Am J Pathol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fped.2017.00272","article-title":"Is autosomal dominant polycystic kidney disease becoming a pediatric disorder?","volume":"5","author":"De Rechter","year":"2017","journal-title":"Front Pediatr"},{"issue":"Suppl 1","key":"10.1053\/j.akdh.2023.01.007_bib20","doi-asserted-by":"crossref","first-page":"I14","DOI":"10.1093\/ckj\/sfy088","article-title":"Unmet needs and challenges for follow-up and treatment of autosomal dominant polycystic kidney disease: the paediatric perspective","volume":"11","author":"De Rechter","year":"2018","journal-title":"Clin Kidney J"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-021-04974-4","article-title":"The wind of change in the management of autosomal dominant polycystic kidney disease in childhood","volume":"37","author":"Gimpel","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2023.01.007_bib22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41581-019-0155-2","article-title":"International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people","volume":"15","author":"Gimpel","year":"2019","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib23","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2215\/CJN.05190422","article-title":"Perspectives on drug development in early ADPKD","volume":"17","author":"Mekahli","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2023.01.007_bib24","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.V3121863","article-title":"Characteristics of very early onset autosomal dominant polycystic kidney disease","volume":"3","author":"Fick","year":"1993","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1053\/j.akdh.2023.01.007_bib25","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00467-010-1617-8","article-title":"Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms","volume":"25","author":"Mekahli","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40746-022-00244-z","article-title":"Changing the outcome of a pediatric disease: Part I \u2014 clinical features of ADPKD","volume":"8","author":"Cadnapaphornchai","year":"2022","journal-title":"Curr Treat Options Pediatr"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000448695","article-title":"Long-term outcomes in patients with very-early onset autosomal dominant polycystic kidney disease","volume":"44","author":"Nowak","year":"2016","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib28","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD","volume":"24","author":"Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1681\/ASN.2017050483","article-title":"Genetic Complexity of autosomal dominant polycystic kidney and liver diseases","volume":"29","author":"Cornec-Le Gall","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib30","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1053\/j.ackd.2010.01.001","article-title":"Hypertension in autosomal dominant polycystic kidney disease","volume":"17","author":"Chapman","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"10.1053\/j.akdh.2023.01.007_bib31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/archdischild-2015-310221","article-title":"Hypertension in autosomal dominant polycystic kidney disease: a meta-analysis","volume":"101","author":"Marlais","year":"2016","journal-title":"Arch Dis Child"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib32","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2215\/CJN.11401017","article-title":"Prevalence of hypertension in children with early-stage ADPKD","volume":"13","author":"Massella","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"24","key":"10.1053\/j.akdh.2023.01.007_bib33","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib34","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib35","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","article-title":"Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease","volume":"8","author":"Johnson","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib36","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","article-title":"Progression of autosomal-dominant polycystic kidney disease in children","volume":"59","author":"Fick-Brosnahan","year":"2001","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2215\/CJN.03780410","article-title":"Magnetic resonance imaging of kidney and cyst volume in children with ADPKD","volume":"6","author":"Cadnapaphornchai","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ki.2008.397","article-title":"Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension","volume":"74","author":"Cadnapaphornchai","year":"2008","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0b013e32835b36c1","article-title":"Renal microvascular dysfunction, hypertension and CKD progression","volume":"22","author":"Bidani","year":"2013","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"11","key":"10.1053\/j.akdh.2023.01.007_bib40","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.2215\/CJN.02240311","article-title":"Relationship between blood pressure and incident chronic kidney disease in hypertensive patients","volume":"6","author":"Hanratty","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib41","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1681\/ASN.2006111199","article-title":"A population-based, prospective study of blood pressure and risk for end-stage renal disease in China","volume":"18","author":"Reynolds","year":"2007","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib42","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1681\/ASN.2017020148","article-title":"Effects of intensive BP control in CKD","volume":"28","author":"Cheung","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94467-z","article-title":"Association of blood pressure and renal outcome in patients with chronic kidney disease; a post hoc analysis of FROM-J study","volume":"11","author":"Tsuchida-Nishiwaki","year":"2021","journal-title":"Sci Rep"},{"issue":"17","key":"10.1053\/j.akdh.2023.01.007_bib44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJMoa0902066","article-title":"Strict blood-pressure control and progression of renal failure in children","volume":"361","author":"W\u00fchl","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib45","first-page":"1908","article-title":"Factors relating to urinary protein excretion in children with autosomal dominant polycystic kidney disease","volume":"9","author":"Sharp","year":"1998","journal-title":"J Am Soc Nephrol. 1998;9"},{"issue":"11","key":"10.1053\/j.akdh.2023.01.007_bib46","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1093\/ndt\/gfv422","article-title":"Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 Trial","volume":"31","author":"Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.akdh.2023.01.007_bib47","first-page":"S54","article-title":"Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The \u201cGruppo Italiano di Studi Epidemiologici in Nefrologia\u201d (GISEN)","volume":"63","author":"Ruggenenti","year":"1997","journal-title":"Kidney Int Suppl"},{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib48","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.akdh.2023.01.007_bib49","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1053\/j.ackd.2011.04.002","article-title":"Implications of proteinuria: CKD progression and cardiovascular outcomes","volume":"18","author":"Sarnak","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"10.1053\/j.akdh.2023.01.007_bib54","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1053\/j.ajkd.2003.12.026","article-title":"Patients with autosomal dominant polycystic kidney disease hyperfiltrate early in their disease","volume":"43","author":"Wong","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib55","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2215\/CJN.01010211","article-title":"Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease","volume":"6","author":"Helal","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib56","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00467-012-2192-y","article-title":"Early renal abnormalities in children with postnatally diagnosed autosomal dominant polycystic kidney disease","volume":"27","author":"Selistre","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000499486","article-title":"Consequences of glomerular hyperfiltration: the role of physical forces in the pathogenesis of chronic kidney disease in diabetes and obesity","volume":"143","author":"Chagnac","year":"2019","journal-title":"Nephron"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0272-6386(12)80541-5","article-title":"Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease","volume":"20","author":"Gabow","year":"1992","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib60","first-page":"629","article-title":"Renal concentrating capacity is linked to blood pressure in children with autosomal dominant polycystic kidney disease","volume":"53","author":"Seeman","year":"2004","journal-title":"Physiol Res"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00467-016-3364-y","article-title":"The spectrum of autosomal dominant polycystic kidney disease in children and adolescents","volume":"32","author":"Reddy","year":"2017","journal-title":"Pediatr Nephrol"},{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib62","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00103-019-03007-8","article-title":"Headache, abdominal and back pain in children and adolescents in Germany: results from KiGGS Wave 2 and trends","volume":"62","author":"Krause","year":"2019","journal-title":"Bundesgesundheitsblatt - Gesundheitsforsch - Gesundheitsschutz"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib63","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1523-1755.2005.00678.x","article-title":"Autosomal-dominant polycystic kidney disease in infancy and childhood: progression and outcome","volume":"68","author":"Shamshirsaz","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib64","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00467-008-1090-9","article-title":"Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease","volume":"24","author":"Fencl","year":"2009","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib66","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00126097-200306000-00003","article-title":"Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease","volume":"8","author":"Seeman","year":"2003","journal-title":"Blood Press Monit"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s004670050343","article-title":"Blood pressure and renal function in autosomal dominant polycystic kidney disease","volume":"11","author":"Seeman","year":"1997","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib70","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ekir.2017.01.003","article-title":"Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease","volume":"2","author":"Perrone","year":"2017","journal-title":"Kidney Int Reports"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib71","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00467-017-3862-6","article-title":"3DUS as an alternative to MRI for measuring renal volume in children with autosomal dominant polycystic kidney disease","volume":"33","author":"Breysem","year":"2018","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.01.007_bib72","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2215\/CJN.02810608","article-title":"Prospective change in renal volume and function in children with ADPKD","volume":"4","author":"Cadnapaphornchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"15","key":"10.1053\/j.akdh.2023.01.007_bib73","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138724","article-title":"The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD","volume":"5","author":"Lavu","year":"2020","journal-title":"JCI Insight"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib74","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1681\/ASN.2017070819","article-title":"Overweight and obesity are predictors of progression in early autosomal dominant polycystic kidney disease","volume":"29","author":"Nowak","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib75","doi-asserted-by":"crossref","first-page":"908","DOI":"10.2215\/CJN.16871020","article-title":"Overweight and obesity and progression of ADPKD","volume":"16","author":"Nowak","year":"2021","journal-title":"Clin J Am Soc\u00a0Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/obr.12334","article-title":"Predicting adult obesity from childhood obesity: a systematic review and meta-analysis","volume":"17","author":"Simmonds","year":"2016","journal-title":"Obes Rev"},{"issue":"23","key":"10.1053\/j.akdh.2023.01.007_bib77","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1056\/NEJMoa072515","article-title":"Childhood body-mass index and the risk of Coronary Heart disease in adulthood","volume":"357","author":"Baker","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib78","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMoa0904130","article-title":"Childhood obesity, other cardiovascular risk factors, and Premature Death","volume":"362","author":"Franks","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40620-017-0377-y","article-title":"Obesity and kidney disease: hidden consequences of the epidemic","volume":"30","author":"Kovesdy","year":"2017","journal-title":"J Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib80","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000308161","article-title":"Obesity-related renal injury in childhood","volume":"73","author":"Savino","year":"2010","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"10.1053\/j.akdh.2023.01.007_bib81","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1159\/000507784","article-title":"Obesity-related Glomerulopathy: a latent change in obesity requiring more Attention","volume":"45","author":"Yang","year":"2020","journal-title":"Kidney Blood Press Res"},{"issue":"10","key":"10.1053\/j.akdh.2023.01.007_bib82","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1097\/01.ASN.0000089565.04535.4B","article-title":"Hypertension and progression of chronic renal insufficiency in children: a report of the North American pediatric renal Transplant Cooperative study (NAPRTCS)","volume":"14","author":"Mitsnefes","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib83","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/j.ackd.2014.09.004","article-title":"Epidemiology of hypertension in CKD","volume":"22","author":"Horowitz","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib84","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.semnephrol.2012.12.002","article-title":"The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases","volume":"33","author":"R\u00fcster","year":"2013","journal-title":"Semin Nephrol"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib85","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00467-013-2500-1","article-title":"Metabolic syndrome in children with chronic kidney disease and after renal transplantation","volume":"29","author":"Litwin","year":"2014","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"10.1053\/j.akdh.2023.01.007_bib86","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2215\/CJN.13291019","article-title":"Metabolic reprogramming in autosomal dominant polycystic kidney disease evidence and therapeutic potential","volume":"15","author":"Nowak","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib87","doi-asserted-by":"crossref","first-page":"109495","DOI":"10.1016\/j.cellsig.2019.109495","article-title":"Metabolic reprogramming and the role of mitochondria in polycystic kidney disease","volume":"67","author":"Podrini","year":"2020","journal-title":"Cell Signal"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib88","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00467-021-05406-z","article-title":"Is autosomal dominant polycystic kidney disease an early sweet disease?","volume":"37","author":"Dachy","year":"2022","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib89","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3389\/fped.2017.00291","article-title":"Is it ethical to test apparently \u201cHealthy\u201d children for autosomal dominant polycystic kidney disease and risk medicalizing thousands?","volume":"5","author":"Harris","year":"2018","journal-title":"Front Pediatr"},{"issue":"11","key":"10.1053\/j.akdh.2023.01.007_bib90","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1007\/s00431-022-04609-2","article-title":"What does the best interests principle of the convention on the rights of the child mean for paediatric healthcare?","volume":"181","author":"M\u00e4rz","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"7","key":"10.1053\/j.akdh.2023.01.007_bib91","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s00467-014-2882-8","article-title":"Rationale for early treatment of polycystic kidney disease","volume":"30","author":"Grantham","year":"2015","journal-title":"Pediatr Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2023.01.007_bib92","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3390\/nu11071576","article-title":"Dietary care for ADPKD patients: current status and future directions","volume":"11","author":"Carriazo","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib93","first-page":"1710","article-title":"Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?","volume":"29","author":"Higashihara","year":"2014","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib94","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100021","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan","year":"2022","journal-title":"NEJM Evid"},{"issue":"20","key":"10.1053\/j.akdh.2023.01.007_bib95","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1056\/NEJMoa1710030","article-title":"Tolvaptan in later-stage autosomal dominant polycystic kidney disease","volume":"377","author":"Torres","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1053\/j.akdh.2023.01.007_bib96","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00431-019-03384-x","article-title":"Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial","volume":"178","author":"Schaefer","year":"2019","journal-title":"Eur J Pediatr"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib97","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib98","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1038\/s41598-017-07300-x","article-title":"Metformin inhibits cyst formation in a Zebrafish model of polycystin-2 Deficiency","volume":"7","author":"Chang","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib99","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/bph.14558","article-title":"The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease","volume":"176","author":"Lian","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib100","doi-asserted-by":"crossref","first-page":"F27","DOI":"10.1152\/ajprenal.00298.2021","article-title":"Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model","volume":"322","author":"Pastor-Soler","year":"2022","journal-title":"Am J Physiol Ren Physiol"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib101","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2021.06.013","article-title":"Primary results of the randomized trial of metformin administration in polycystic kidney disease (TAME PKD)","volume":"100","author":"Perrone","year":"2021","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.akdh.2023.01.007_bib102","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/j.ajkd.2021.06.026","article-title":"Metformin therapy in autosomal dominant polycystic kidney disease: a Feasibility study","volume":"79","author":"Brosnahan","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib103","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.2337\/dc09-0258","article-title":"Metformin for obesity in children and adolescents: a systematic review","volume":"32","author":"Min","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib104","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1210\/jc.2012-2710","article-title":"Metformin in obese children and adolescents: the MOCA trial","volume":"98","author":"Kendall","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib105","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/00365590903359908","article-title":"Effect of pravastatin on kidney function and urinary protein excretion in autosomal dominant polycystic kidney disease","volume":"44","author":"Fassett","year":"2010","journal-title":"Scand J Urol Nephrol"},{"issue":"6","key":"10.1053\/j.akdh.2023.01.007_bib106","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.3390\/ijms23063317","article-title":"Autosomal dominant polycystic kidney disease: from Pathophysiology of cystogenesis to advances in the treatment","volume":"23","author":"Reiterov\u00e1","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1053\/j.akdh.2023.01.007_bib107","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.08350813","article-title":"Effect of pravastatin on total kidney volume, left ventricular mass index, and Microalbuminuria in pediatric autosomal dominant polycystic kidney disease","volume":"9","author":"Cadnapaphornchai","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.akdh.2023.01.007_bib108","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib109","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2215\/CJN.11331114","article-title":"Pravastatin therapy and biomarker changes in children and young adults with autosomal dominant polycystic kidney disease","volume":"10","author":"Klawitter","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2023.01.007_bib110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3892\/mmr.2021.11834","article-title":"Combination of curcumin and ginkgolide B inhibits cystogenesis by regulating multiple signaling pathways","volume":"23","author":"Li","year":"2021","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1053\/j.akdh.2023.01.007_bib111","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1038\/s41598-019-41106-3","article-title":"Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis","volume":"9","author":"Patera","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1053\/j.akdh.2023.01.007_bib112","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2215\/CJN.08950621","article-title":"Curcumin therapy to Treat vascular dysfunction in children and young adults with ADPKD A randomized controlled trial","volume":"17","author":"Nowak","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2023.01.007_bib113","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ekir.2019.05.015","article-title":"ADPedKD: a global online platform on the management of children with ADPKD","volume":"4","author":"De Rechter","year":"2019","journal-title":"Kidney Int Reports"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813923000149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:11:35Z","timestamp":1762650695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813923000149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":105,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2949813923000149"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2023.01.007","relation":{},"ISSN":["2949-8139"],"issn-type":[{"value":"2949-8139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autosomal Dominant Polycystic Kidney Disease in Children and Adolescents: Assessing and Managing Risk of Progression","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2023.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}